Thomas Stephan
Stock Analyst at Stifel
(4.80)
# 155
Out of 4,479 analysts
28
Total ratings
78.95%
Success rate
21.53%
Average return
Main Sectors:
Top Industries:
7 Stocks
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| GKOS Glaukos | Maintains: Buy | $110 → $130 | $118.98 | +9.26% | 5 | Jun 5, 2024 | |
| IRIX IRIDEX | Maintains: Hold | $2 | $2.01 | -0.50% | 2 | May 15, 2024 | |
| ALC Alcon | Reiterates: Buy | $95 → $100 | $88.79 | +12.63% | 4 | May 15, 2024 | |
| RXST RxSight | Maintains: Buy | $64 → $68 | $57.04 | +19.21% | 4 | May 6, 2024 | |
| STAA STAAR Surgical Company | Maintains: Buy | $50 | $44.52 | +12.31% | 7 | Apr 1, 2024 | |
| SGHT Sight Sciences | Maintains: Buy | $6 → $7 | $6.16 | +13.64% | 5 | Mar 8, 2024 | |
| BLCO Bausch + Lomb | Initiates: Hold | $16 | $14.66 | +9.14% | 1 | Dec 12, 2023 |
Glaukos
Jun 5, 2024
Maintains: Buy
Price Target: $110 → $130
Current: $118.98
Upside: +9.26%
IRIDEX
May 15, 2024
Maintains: Hold
Price Target: $2
Current: $2.01
Upside: -0.50%
Alcon
May 15, 2024
Reiterates: Buy
Price Target: $95 → $100
Current: $88.79
Upside: +12.63%
RxSight
May 6, 2024
Maintains: Buy
Price Target: $64 → $68
Current: $57.04
Upside: +19.21%
STAAR Surgical Company
Apr 1, 2024
Maintains: Buy
Price Target: $50
Current: $44.52
Upside: +12.31%
Sight Sciences
Mar 8, 2024
Maintains: Buy
Price Target: $6 → $7
Current: $6.16
Upside: +13.64%
Bausch + Lomb
Dec 12, 2023
Initiates: Hold
Price Target: $16
Current: $14.66
Upside: +9.14%